SABIC to complete purchase of stake in Clariant

By Lucy Whitehouse

- Last updated on GMT

SABIC to complete purchase of stake in Clariant
Clariant, global specialty chemicals company, has confirmed that SABIC is to complete a purchase of a 24.99% stake in it, after receiving all regulatory approvals.

SABIC is the world’s third largest diversified chemical company, and has been a long-standing partner of Clariant in the company’s Catalyst joint venture, Scientific Design.

It entered into a purchase agreement regarding the acquisition of the stake in Clariant in January 2018, and has now received the final outstanding regulatory approvals from the competition authorities.

This means an unconditional closing of the purchase is now possible, making SABIC Clariant’s largest strategic anchor shareholder, and second anchor shareholder beside the group of former shareholders of Süd-Chemie.

With SABIC receiving all the regulatory approvals and the transaction set to be completed, we look forward to further developing the strategic relationship between both companies in order to generate value for all stakeholders​”, said Hariolf Kottmann, CEO of Clariant.

The two companies say they are discussing possible future collaborations that will generate value for the stakeholders of both companies, and any outcome of these discussions will be presented in due course.

Saudi Arabia headquarters: MENA focus?

SABIC is headquartered in Riyadh, Saudi Arabia, and while it manufactures on a global scale in the Americas, Europe, Middle East, the move will no doubt particularly strengthen Clariant’s position in the Middle East and North Africa (MENA) region.

Earlier this year, Clariant’s annual financial results showed​ sales growth in local currency was strongest in the Middle East & Africa in 2017, at 15%.

Sales in Asia rose by 12%, lifted by a ‘remarkable sales development’ in China, Southeast Asia and Japan, and sales grew by 7% in Europe.

In local currency of Swiss francs, the company saw its sales jump to CHF 6.377 billion, with net income climbing by 15% to reach CHF 302 million.

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast